Even worse is a growing trend to invert this process: to promote diseases to fit existing drugs. In a fascinating New York Review of Books piece, Marcia Angell, M.D., denounced the practice of "disease mongering." As she put it, "The strategy is to convince as many people as possible (along with their doctors, of course) that they have medical conditions that require long-term drug treatment."
A British Medical Journal article said it more succinctly, "A lot of money can be made from healthy people who believe they are sick."
Disease Mongering: Good for Big Pharma, Bad for You
Since September, 16 major drug companies have inked deals with the Trump administration to lower prices....
